Ardelyx (ARDX) Trading Update – 23 October 2026
Current Price
05:07 AM Central Europe, Friday 23 October 2026: USD 3.20 per share.
The share price is down 2.49 % compared with the previous 24‑hour period.
Trading Volume
24‑hour volume: USD 9.4 million.
Shares outstanding: 258.2 million.
Market capitalization: USD 809.4 million.
Price History
52‑week high: USD 8.40 (23 January 2026).
52‑week low: USD 3.05 (19 October 2026).
Simple moving average (200 days): USD 5.46.
Recent Performance
Since the end of last month: –13.54 % decline.
Related Stock Performance (last 24 hours)
| Ticker | Recent Move | Current Price (USD) | Market Capitalization (USD mn) | P/E Ratio |
|---|---|---|---|---|
| CGEM (Cullinan Therapeutics) | +0.4 % | 14.92 | 955 | – |
| MGTX (Meiragtx) | –1.1 % | 9.77 | 957.6 | 10.67 |
| CAC (Camden National) | –0.81 % | 57.86 | 953.8 | 10.88 |
| ANRO (Alto Neuroscience) | –4.47 % | 22.2 | 965 | – |
| GLUE (Monte Rosa Therapeutics) | –1.23 % | 11.11 | 969.2 | – |
Company Overview
Ardelyx, Inc. is a biotechnology company headquartered in Fremont, United States. The company develops pharmaceutical products that target mineral metabolism and metabolic disorders by modulating transporters, channels, and receptors in the gastrointestinal epithelium. Its therapies are intended for patients within the United States. Ardelyx trades on the Nasdaq stock exchange and completed its initial public offering in June 2014. For additional information, visit the company’s website at www.ardelyx.com .
